IMARC Group’s latest report, titled “Substance Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033“, finds that the global substance use disorder market size is witnessing steady growth. Substance use disorder (SUD) is a persistent, relapsing medical condition characterized by compulsive drug or alcohol use, with severe consequences on an individual's physical and mental health, relationships, and overall quality of life. It can arise from the use of recreational drugs or the extended use of prescription medications like painkillers. Its symptoms may vary depending on the substance, frequency, amount of use, and the individual's medical and personal history. Some common indications include an intense craving for drugs or alcohol, persistent substance use despite the negative consequences, and withdrawal symptoms such as nausea, sweating, anxiety, agitation, and insomnia. Other signs may include social, financial, and legal problems and damaged relationships with family and friends. Currently, SUD can be diagnosed by a comprehensive evaluation by a healthcare professional, including medical history, physical examination, and behavioral assessment across the globe.
Global Substance Use Disorder Market Trends:
Increasing consumption of tobacco and alcohol represents the primary factor driving the market growth. Moreover, the rising popularity of outpatient rehabilitation programs that provide regular treatment, including therapy or medication-assisted treatment (MAT), to individuals living at home is positively influencing the market growth. Additionally, several favorable initiatives by governments of numerous countries to raise awareness about substance use disorder as a treatable medical condition, reducing the associated stigma and encouraging more individuals to seek treatment, have catalyzed market growth. Besides this, the introduction of private insurance coverage for substance abuse disorder treatment, making it more accessible and affordable for individuals, is propelling market growth. Furthermore, the rising utilization of holistic therapeutic approaches, such as yoga, meditation, and acupuncture, combined with traditional SUD treatments, is contributing to the market growth. Apart from this, the surging adoption of behavioral therapies, including cognitive-behavioral therapy (CBT) and motivational interviewing, which help identify and change negative thought patterns and behaviors related to substance abuse, is another major growth-inducing factor. Other factors, including increasing usage of prescription or illicit drugs, the rising number of treatment centers, and rapid digitization, are also anticipated to create a positive market outlook.
- Country-wise, the market has been segregated into the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for substance use disorder.
- The study also offers a thorough overview of the treatment practices for substance use disorder, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800